Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 284

1.
2.
3.

Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).

Oosterhuis B, Brannan MD, Groen H, Peeters PA, Hempenius J, Radwanski E, Nomeir AA, Affrime MB, Jonkman JH.

Ann Allergy Asthma Immunol. 1995 Aug;75(2):157-61.

PMID:
7648380
4.

The clinical significance of food-induced changes in the absorption of theophylline from Uniphyl tablets.

Arkinstall WW, Hopkinson M, Rivington RN, Calcutt L, Aitken T, Stewart JH.

J Allergy Clin Immunol. 1988 Aug;82(2):155-64.

PMID:
3273483
5.

Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily.

Götz J, Sauter R, Steinijans VW, Jonkman JH.

Int J Clin Pharmacol Ther. 1994 Apr;32(4):168-73.

PMID:
8032575
6.

[24-hour lung function in asthmatic patients: chrono-optimal theophylline therapy as once-daily Euphylong administration vs conventional twice-daily administration].

D'Alonzo GE, Smolensky MH, Feldman S, Gianotti LA, Emerson MB, Staudinger HW, Sauter R, Steinijans VW.

Pneumologie. 1991 Nov;45 Suppl 4:834-41. German.

PMID:
1812476
7.
8.

The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.

Yamazaki M, Fukutomi O, Kondo N, Kato Z, Nakashima Y, Shinoda S, Agata H, Kondo T, Imaeda N, Orii T.

Int J Clin Pharmacol Ther. 1994 Nov;32(11):625-31.

PMID:
7874380
9.

[Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route].

Albertini M, Lapalus P, Maurin S, Boutte P, Mariani R.

Arch Fr Pediatr. 1982 Nov;39(9):671-5. French.

PMID:
7165461
11.

The consistency of theophylline absorption from a sustained-release formulation in asthmatic children.

Hill M, Haltom JR, Szefler SJ.

Pharmacotherapy. 1988;8(5):277-83.

PMID:
3255299
12.

Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.

Leeder JS, Robertson C, Correia J, Isles AF, Levison H, Macleod SM.

Ann Allergy. 1986 Feb;56(2):133-7.

PMID:
3946845
13.
15.

Conversion from intravenous to sustained-release oral theophylline in pediatric patients with asthma.

Clarke DF, Werbowsky OL, Grodin MA, Shargel L.

Drug Intell Clin Pharm. 1986 Sep;20(9):700-3.

PMID:
3757784
16.

Conversion from intravenous to oral dosing using sustained-release theophylline tablets.

Stein GE, Haughey DB, Ross RJ, Vakoutis J.

Drug Intell Clin Pharm. 1982 Oct;16(10):772-4.

PMID:
7140514
18.

The use of a single daily theophylline dose and metered-dose albuterol in asthma treatment.

Busse WW, Smith A, Bush RK.

J Allergy Clin Immunol. 1986 Oct;78(4 Pt 1):577-82.

PMID:
3771949
19.
20.

Supplemental Content

Support Center